Business Wire

NY-EMPIRE-STATE-REALTY

13.2.2024 23:24:29 CET | Business Wire | Press release

Share
The Empire State Building Introduces Ambassador Program for Superfans of its World-Famous Observatory Experience

Be an ESB VIP. The Empire State Building (ESB) announced today its new ambassador program for locals who host guests in New York City and superfans of its world-famous Observatory Experience. Visitors earn points in the loyalty program for each ticket purchased on the ESB website for the 86th and 102nd Floor Observatories and redeem them for complimentary experiences and collectibles.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240213973067/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Rewards to include exclusive NFTs, complimentary tickets, and special experiences. (Photo: Business Wire)

“Each visit to the Empire State Building is unique, and we made it easier for our loyal locals who bring their guests and our superfans to take in our reimagined Observatory’s exhibits and unparalleled views time and time again,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “We want to show our fans our appreciation for their loyalty and offer exclusive access to premium, authentic experiences and the best views from the heart of New York City.”

Members will progress through four tiers and collect rewards at each tier which include:

  • Ambassador (Unlocked at 0-439 points)
    • Has registered for the program
    • Not yet eligible for any benefits
  • Bronze Ambassador (Unlocked at 440 points)
    • Inclusion in our Ambassadors’ Newsletter
    • One ticket to the 86th Floor Observatory
    • One lottery entry for access for two (2) guests to one of the exclusive ESB influencer or celebrity appearances events. Non-transferable.
  • Silver Ambassador (Unlocked at 880 points)
    • Inclusion in our Ambassadors’ Newsletter
    • One additional ticket to the 86th Floor Observatory
    • One additional lottery entry for access for two (2) guests to one of the exclusive ESB influencer or celebrity visit events. Non-transferable.
  • Gold Ambassador (Unlocked at 1,320 points)
    • Inclusion in our Ambassadors’ Newsletter
    • Two tickets to the 86th and 102nd Floor Observatories
    • Two tickets to a scheduled Saturday morning Sunrise Experience
    • Two entries to the coveted annual Empire State Building Run-Up (assignable to a family member or friend) or lottery entry for access for two (2) guests to one of the exclusive ESB influencer or celebrity visit events. Non-transferable.
  • Platinum Ambassador (Unlocked at 1,760 points)
    • Inclusion in our Ambassadors’ Newsletter
    • Four tickets to the 86th and 102nd Floor Observatories
    • Four tickets to a scheduled Saturday morning Sunrise Experience
    • One entry to the coveted annual Empire State Building Run-Up (assignable to a family member or friend).
    • Entry for access for four (4) guests to one of the exclusive ESB influencer or celebrity visit events. Non-transferable

Each new member of the Ambassador Program will receive a custom NFT upon signup. For each tier achieved, members will receive additional custom NFTs, developed and distributed in partnership with Uptop, which feature the “World’s Most Famous Building” against an Art Deco backdrop in the tier’s respective metallic tone. The exclusive NFTs serve as a digital keepsake and a key to unlock their personalized rewards.

Visitors who join the Ambassador Program who purchased tickets on or after Feb. 1, 2024 will automatically receive points and the new member NFT for their last purchase retroactively. Points and status acquired remain until redemptions and do not expire.

The Empire State Building Observatory recently underwent a $165 million reimagination that includes a dedicated visitor entrance, an immersive museum with nine galleries, brand new bespoke Observatory Host uniforms, and iconic 86th and 102nd Floor Observatories. The reimagined Observatory Experience was recently voted the number one attraction in the U.S. by Tripadvisor travelers for two consecutive years.

Registration for the Ambassador Program can be found here.

Hi-res imagery can be found here. More information about the Empire State Building Observatory can be found online.

About the Empire State Building

The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the US for the second year in a row in Tripadvisor’s 2023 Travelers’ Choice Awards: Best of the Best, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.

Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.

Source: Empire State Realty Trust, Inc.

Category: Observatory

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240213973067/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release

~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye